Advanced Malignant Tumor
19
1
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (19)
A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors
Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors
BAT7104 Injection in Patients With Advanced Malignant Tumors.
The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor
A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors
Phase I/II Clinical Trial of LBL-015 for Injection
Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies
Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors
Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors
A Study of QL1706 in Subjects With Advanced Malignant Tumor
QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors
A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor
Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors
Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors
A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors
A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies
A Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant Tumor
An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor
A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor